Coherus Oncology, Inc. Loans Payable, Current
Coherus Oncology, Inc. (CHRS) had Loans Payable, Current of $175.00 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current
us-gaap:LoansPayableCurrent · last filed 2024-05-09
- 2024-03-31: Loans Payable, Current $175.00M.
- 2021-09-30: Loans Payable, Current $17.31M.
- 2021-06-30: Loans Payable, Current $11.54M.
| Period end | Loans Payable, Current |
|---|---|
| 2024-03-31 | $175.00M 10-Q · filed 2024-05-09 |
| 2021-09-30 | $17.31M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $11.54M 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |